CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases

Valeria Cento1, Luna Colagrossi2, Irene Bossi3

  • 1Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy - valeria.cento@unimi.it.

Minerva Medica
|October 18, 2022
PubMed

Insights

Cytomegalovirus (CMV) reactivation may trigger acute coronary syndromes (ACS). CMV-DNAemia was detected in coronary circulation of ACS patients, particularly those without cardiovascular risk factors, suggesting a potential link.

Area of Science:

  • Cardiology
  • Virology
  • Immunology

Background:

  • Acute coronary syndromes (ACS) represent a significant global health burden.
  • Cytomegalovirus (CMV) reactivation is a potential, yet unproven, trigger for cardiovascular events.
  • Understanding the role of CMV in ACS pathogenesis is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential role of coronary and systemic cytomegalovirus (CMV) reactivation as a trigger for acute coronary syndromes (ACS).
  • To establish a proof-of-concept for CMV involvement in the pathophysiology of ACS.
  • To compare CMV prevalence and DNAemia in ACS patients versus non-ACS controls.

Main Methods:

  • Prospective enrollment of 193 patients undergoing coronary angiography for ACS (n=136) or non-ACS reasons (n=57).
  • Quantification of CMV-DNAemia, CMV-IgG/IgM, and CMV-IgG avidity in matched coronary and peripheral blood samples using RT-PCR and ELISA.
  • Inclusion of 17 healthy subjects as controls for CMV seroprevalence comparison.

Main Results:

  • High CMV-IgG seroprevalence (91.7%) observed in patients, significantly higher than controls (52.9%).
  • Low-level CMV-DNAemia detected in 22.6% of patients, with coronary CMV-DNAemia more frequent in acute ACS cases lacking cardiovascular risk factors (40.0%) compared to chronic cases (10.9%) or acute cases with risk factors (14.3%).
  • No evidence of acute CMV infection; findings support a long history of CMV infection.

Conclusions:

  • High CMV seroprevalence in patients with heart disease underscores the virus's widespread presence.
  • CMV-DNAemia, though uncommon, is present in coronary circulation during ACS, particularly in older individuals and those without traditional cardiovascular risk factors.
  • These findings highlight potential avenues for novel interventions targeting CMV in ACS management.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
46
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31